Latest Articles

Mass spec systems are helping biomedical researchers gain deeper insight into the mechanisms of disease progression and therapeutic intervention, but the sheer volume and complexity of samples are challenging instrument makers to innovate.

We ask leading experts about metabolomics potential to transform the future of healthcare.

From its development in the late 1940s and early 1950s, NMR spectroscopy has gone on to become the predominant method for the analysis of organic compounds.

Using existing screening libraries can efficiently repurpose drugs for new therapeutic purposes, by bypassing development stages.

Learn about novel antibody-based strategies for boosting the immune system to control cancer.

High throughput screening continues to drive early-stage drug discovery through technological advances and process optimization.

Study using Rhesus monkeys describes how the Zika virus can hide from the body's immune system in brain and lymph tissue for up 72 days. And also describes the possible mechanism by which Zika causes microcephaly in gestating babies.

Recipient of this year's Clemson Award for Contributions to the Literature, Dr. Khademhosseini tells us a little about his career and the work his lab is doing to develop innovative biomaterials that can help address a variety of biomedical challenges.

With such tremendous amounts of data being produced, adequate storage capacity and methodology will be crucial for the advancement of genomic research and medicine.

Limitations of current planar, static cell culture systems or animal models highlight the urgent need for more physiologically relevant models of human organs, and have fuelled the development of organs-on-chips.